SBRT for Early-Stage Lung Cancer Reaches Decade Milestone

Researchers from the Cleveland Clinic Foundation analyzed 10 years of data to reveal that early stage lung cancer patients with medically inoperable tumors who received high-dose rate stereotactic body radiation therapy (SBRT) experienced long-term local tumor control and minimal toxicity.

The study demonstrated that SBRT can reduce the growth and spread of a primary, early-stage lung tumor while minimizing radiation exposure to healthy tissue. Read the full study here.

Illinois CyberKnife delivers SBRT using CyberKnife® technology. The treatment does not require surgery or sedation. Patients typically experience few to no side effects and can return to their normal routines immediately following each treatment session.

If you or a loved one has been diagnosed with early-stage lung cancer, contact our center to learn more about SBRT as a treatment option.

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.